Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson's disease

Exp Neurol. 2023 Nov 23:114614. doi: 10.1016/j.expneurol.2023.114614. Online ahead of print.ABSTRACTAbnormal iron accumulation has been implicated in the etiology of Parkinson's disease (PD). Understanding how iron damages dopaminergic neurons in the substantia nigra (SN) of PD is particularly important for developing targeted neurotherapeutic strategies for the disease. However, it is still not fully understood how excess iron contributes to the neurodegeneration of dopaminergic neurons in PD. There has been increased attention on mitochondrial iron dyshomeostasis, iron-induced mitochondrial dysfunction and ferroptosis in PD. Therefore, this review begins with a brief introduction to describe cellular iron metabolism and the dysregulation of iron metabolism in PD. Then we provide an update on how iron is delivered to mitochondria and induces the damage of dopaminergic neurons in PD. In addition, we also summarize new research progress on iron-dependent ferroptosis in PD and mitochondria-localized proteins involved in ferroptosis. This will provide new insight into potential therapeutic strategies targeting mitochondrial iron dysfunction.PMID:38007207 | DOI:10.1016/j.expneurol.2023.114614
Source: Experimental Neurology - Category: Neurology Authors: Source Type: research